H.B. Fuller (NYSE:FUL) Given New $60.00 Price Target at JPMorgan Chase & Co.

H.B. Fuller (NYSE:FUL) had its price objective reduced by JPMorgan Chase & Co. from $70.00 to $60.00 in a research report sent to investors on Friday morning,Benzinga reports. They currently have an underweight rating on the specialty chemicals company’s stock.

Several other analysts have also recently commented on the stock. Vertical Research cut shares of H.B. Fuller from a “buy” rating to a “hold” rating in a research note on Monday, January 6th. Citigroup reduced their price target on shares of H.B. Fuller from $78.00 to $68.00 and set a “neutral” rating for the company in a research report on Friday, January 3rd. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $84.20.

H.B. Fuller Price Performance

Shares of NYSE:FUL opened at $62.14 on Friday. The company has a quick ratio of 1.16, a current ratio of 1.89 and a debt-to-equity ratio of 1.10. The company has a 50-day moving average price of $70.82 and a 200 day moving average price of $76.79. H.B. Fuller has a 52 week low of $60.96 and a 52 week high of $87.67. The company has a market cap of $3.39 billion, a P/E ratio of 19.18, a PEG ratio of 1.50 and a beta of 1.43.

H.B. Fuller (NYSE:FUL) last announced its quarterly earnings data on Wednesday, January 15th. The specialty chemicals company reported $0.92 earnings per share for the quarter, missing analysts’ consensus estimates of $1.00 by ($0.08). H.B. Fuller had a return on equity of 13.39% and a net margin of 5.15%. The business had revenue of $923.00 million for the quarter, compared to analyst estimates of $916.84 million. During the same period in the prior year, the company earned $1.32 EPS. The company’s revenue was up 2.2% on a year-over-year basis. Research analysts predict that H.B. Fuller will post 3.84 earnings per share for the current year.

Institutional Trading of H.B. Fuller

Institutional investors and hedge funds have recently modified their holdings of the business. S&CO Inc. raised its position in shares of H.B. Fuller by 0.3% during the 3rd quarter. S&CO Inc. now owns 267,192 shares of the specialty chemicals company’s stock worth $21,209,000 after purchasing an additional 920 shares during the last quarter. Wesbanco Bank Inc. increased its position in H.B. Fuller by 41.2% during the fourth quarter. Wesbanco Bank Inc. now owns 13,700 shares of the specialty chemicals company’s stock worth $924,000 after buying an additional 4,000 shares in the last quarter. Geode Capital Management LLC raised its holdings in shares of H.B. Fuller by 1.5% in the third quarter. Geode Capital Management LLC now owns 1,258,752 shares of the specialty chemicals company’s stock worth $99,939,000 after acquiring an additional 18,734 shares during the last quarter. Marshall Wace LLP lifted its position in shares of H.B. Fuller by 9.9% in the second quarter. Marshall Wace LLP now owns 290,005 shares of the specialty chemicals company’s stock valued at $22,319,000 after acquiring an additional 26,239 shares in the last quarter. Finally, Lord Abbett & CO. LLC boosted its stake in shares of H.B. Fuller by 79.8% during the third quarter. Lord Abbett & CO. LLC now owns 730,058 shares of the specialty chemicals company’s stock valued at $57,952,000 after acquiring an additional 324,056 shares during the last quarter. Hedge funds and other institutional investors own 95.93% of the company’s stock.

About H.B. Fuller

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.